Document:

<PAGE>

                                                                    EXHIBIT 4.16

                                     WARRANT

THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE U.S.
SECURITIES ACT OF 1933 (THE "ACT") OR APPLICABLE STATE SECURITIES LAWS, AND THE
TRANSFER THEREOF IS PROHIBITED EXCEPT IN ACCORDANCE WITH THE PROVISIONS THE ACT,
PURSUANT TO REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM SUCH REGISTRATION. HEDGING TRANSACTIONS
INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE
ACT.

                WARRANT TO PURCHASE 8,000 SHARES OF COMMON STOCK
                                       OF
                           SINOFRESH HEALTHCARE, INC.
                  DATE OF ORIGINAL ISSUANCE: September 8, 2003
                                     NO. ___

      This certifies that, Bristol Investment Partners I or their assignees (the
"Holder"), is entitled, subject to the terms set forth below, to purchase from
SinoFresh HealthCare, Inc., a Florida corporation (the "Company"), eight
thousand (8,000) shares of Common Stock of the Company, no par value per share
(the "Warrant Shares"), as constituted on the date hereof (the "Warrant Issue
Date"), upon surrender hereof, at the principal office of the Company referred
to below, with the subscription form attached hereto duly executed, and
simultaneous payment therefor in lawful money of the United States or otherwise
as hereinafter provided, at the exercise price as set forth in Section 2 below
(the "Exercise Price"). The number, character and Exercise Price of the Warrant
Shares is subject to adjustment as provided below. The term "Warrant" as used
herein shall include this Warrant and any warrants delivered in substitution or
exchange therefor as provided herein.

      This Warrant is issued as a replacement for a warrant for 20,000 shares of
common stock issued to Holder on September 8, 2003 (the "Prior Warrant'), of
which Holder transferred rights with respect to 12,000 shares to a third party.
Such Prior Warrant is null and void. (Such Prior Warrant was issued as a
replacement for a warrant issued by SinoFresh HealthCare, Inc., a Delaware
corporation, in the amount of 20,000 shares at an exercise price of $0.50 per
share, which warrant is also null and void.)

      1. Term of Warrant. The purchase right represented by this Warrant shall
terminate on or before 5:30 p.m., Pacific Time, on September 8, 2007
(the "Expiration Date").

      2. Exercise Price. The Exercise Price at which this Warrant may be
exercised shall be One Dollar ($1.00) per share of Common Stock.

      3. Exercise of Warrant. There is no obligation to exercise all or any
portion of the Warrant. The Warrant (or any portion thereof) may be exercised at
any time after the date hereof only by delivery to the Company of:

<PAGE>

            (a) Written notice of exercise in form and substance identical to
Exhibit A attached to this Warrant; and

            (b) Payment of the Exercise Price of the Warrant Shares being
purchased, may be made by (1) cash or by check, (2) cancellation of indebtedness
of the Company to the Holder equal to the Exercise Price, (3) a cashless
exercise procedure pursuant to a formula ("Formula Cashless Exercise"), or (4)
any combination of the foregoing. In the event of a Formula Cashless Exercise,
the Holder shall surrender this Warrant to the Company with a written notice of
the Holder's intention to effect a cashless exercise, including a calculation of
the number of shares of Common Stock to be issued upon such exercise in
accordance with the terms hereof; and, in lieu of paying the Exercise Price in
cash, the Holder shall surrender this Warrant for that number of shares of
Common Stock determined by multiplying the number of Warrant Shares to which it
would otherwise be entitled by a fraction, the numerator of which shall be the
difference between (i) the average Market Price per share of the Common Stock
for the five (5) Trading Days immediately prior to the date of delivery of the
cashless exercise notice to the Company (the "Cashless Exercise Market Price")
and (ii) the Exercise Price, and the denominator of which shall be the Cashless
Exercise Market Price. As used herein, "Market Price" means, as of any Trading
Day, (i) the closing bid price for the shares of Common Stock on the NASD OTC
Bulletin Board ("OTCBB") as reported by Bloomberg, or (ii) if the OTCBB is not
the principal trading market for the shares of Common Stock, the closing bid
price on the principal trading market for the Common Stock as reported by
Bloomberg, or (iii) if market value cannot be calculated as of such date on any
of the foregoing basis, the Market Price shall be the fair market value as
reasonably determined in good faith by the Company and the Holder. If the
parties are unable to agree on the value of the Warrants, their value will be
determined by arbitration in accordance with the rules of the American
Arbitration Association and judgment upon the award entered by the arbitrators
may be entered in any court having jurisdiction. Each party will pay its own
costs in connection with the arbitration, and the cost of the arbitration itself
will be borne equally by the parties. As used herein, a "Trading Day" shall mean
any day on which the Common Stock is traded for any period on the OTCBB, or on
the principal securities exchange or other securities market on which the Common
Stock is then being traded.

      4. No Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be
entitled, the Company shall make a cash payment equal to the Exercise Price
multiplied by such fraction.

      5. Replacement of Warrant. On receipt of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of this Warrant
and, in the case of loss, theft or destruction, on delivery of an indemnity
agreement reasonably satisfactory in form and substance to the Company or, in
the case of mutilation, on surrender and cancellation of this Warrant, the
Company at its expense shall execute and deliver, in lieu of this Warrant, a new
warrant of like tenor and amount.

      6. Rights of Shareholders. Except as otherwise provided herein, this
Warrant shall not entitle its Holder to any of the rights of a shareholder of
the Company.

                                       2
<PAGE>

      7. Transfer of Warrant.

            (a) Restrictions on transfer of Warrant. This Warrant may be
transferred or assigned in whole or in part. The Warrant may be transferred in
whole or in part to an employee, affiliate, or person controlling or controlled
by or under the common control with the Holder or by operation of law as the
result of the death or divorce of any transferee to whom the Warrants may have
been transferred.

            (b) Exchange of Warrant Upon a Transfer. On surrender of this
Warrant for exchange and subject to the provisions of this Warrant with respect
to compliance with the limitations on transfers contained in this Section 7, the
Company at its expense shall issue to or on the order of the Holder a new
warrant or warrants of like tenor, in such names as the Holder may direct, for
the number of shares issuable upon exercise hereof.

      8. Reservation of Stock. The Company covenants that during the term this
Warrant is exercisable, the Company will reserve from its authorized and
unissued Common Stock a sufficient number of shares to provide for the issuance
of Common Stock upon the exercise of this Warrant and, from time to time, will
take all steps necessary to amend its Articles of Incorporation, as amended,
(the "Articles") to provide sufficient reserves of shares of Common Stock
issuable upon exercise of the Warrant. The Company further covenants that all
shares that may be issued upon the exercise of rights represented by this
Warrant and payment of the Exercise Price, all as set forth herein, will be free
from all taxes, liens and charges in respect of the issue thereof (other than
taxes in respect of any transfer occurring contemporaneously or otherwise
specified herein). The Company agrees that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for
shares of Common Stock upon the exercise of this Warrant, and that such
certificates shall be issued in the names of, or in such names as may be
directed by, the Holder.

      9. Notices.

            (a) In case:

                  (i) the Company shall take a record of the holders of its
      Common Stock (or other stock or securities at the time receivable upon the
      exercise of this Warrant) for the purpose of entitling them to receive any
      dividend or other distribution, or any right to subscribe for or purchase
      any shares of stock of any class or any other securities, or to receive
      any other right, or

                  (ii) of any capital reorganization of the Company, any
      reclassification of the capital stock of the Company, any consolidation or
      merger of the Company with or into another corporation, or any conveyance
      of all or substantially all of the assets of the Company to another
      corporation, or

                  (iii) of any voluntary dissolution, liquidation or winding-up
      of the Company, then, and in each such case, the Company will deliver or
      cause to be delivered to the Holder or Holders a notice specifying, as the
      case may be, (A) the date on which a record is to be taken for the purpose
      of such dividend, distribution or right, and stating the amount and
      character of such dividend, distribution or right, or (B) the date on
      which such

                                       3
<PAGE>

      reorganization, reclassification, consolidation, merger, conveyance,
      dissolution, liquidation or winding-up is to take place, and the time, if
      any is to be fixed, as of which the holders of record of Common Stock (or
      such other stock or securities at the time receivable upon the exercise of
      this Warrant) shall be entitled to exchange their shares of Common Stock
      (or such other stock or securities) for securities or other property
      deliverable upon such reorganization, reclassification, consolidation,
      merger, conveyance, dissolution, liquidation or winding-up. Such notice
      shall be delivered at least 15 days prior to the date therein specified.

      10. Amendments.

            (a) Any term of this Warrant may be amended with the written consent
of the Company, Holder and the holders of warrants representing not less than
fifty percent (50%) of the shares of Common Stock issuable upon exercise of any
and all outstanding Warrants. Any amendment effected in accordance with this
Section 10 shall be binding upon each holder of any of the Warrants, each future
holder of all such Warrants, and the Company; provided, however, that no special
consideration or inducement may be given to any such holder in connection with
such consent that is not given ratably to all such holders, and that such
amendment must apply to all such holders equally and ratably in accordance with
the number of shares of Common Stock issuable upon exercise of their Warrants.
The Company shall promptly give notice to all holders of Warrants of any
amendment effected in accordance with this Section 10.

            (b) No waivers of, or exceptions to, any term, condition or
provision of this Warrant, in any one or more instances, shall be deemed to be,
or construed as, a further or continuing waiver of any such term, condition or
provision.

      11. Registration Rights.

            (a) Piggyback Registration. If, at any time commencing after the
date hereof and expiring five (5) years thereafter, the Company, subsequent to
the Company's initial public offering of Common Stock and/or initial "shelf'
registration, proposes to register any of its securities under the Securities
Act of 1933, as amended (the "Act") (other than pursuant to a Form S-4, Form S-8
or any other successor form of limited purpose), it will give written notice by
registered mail at least 30 days prior to the filing of each such registration
statement, to the Holder of its intention to do so. If the Holder notifies the
Company within 20 business days after receipt of any such notice of its or their
desire to include any of their respective Warrant Shares in such proposed
registration statement, the Company shall afford such Holder the opportunity to
have any such Warrant Shares registered under such registration statement;
provided, however, that if the Company advises the Holder in writing that the
inclusion of all Warrant Shares that Holder has proposed be included in such
registration statement would interfere with the successful marketing of the
securities proposed to be registered by the Company, then the securities to be
included in such registration statement shall be included in the following
order:

                  (i) first, the securities proposed to be included in such
      registration by the Company or, if such registration is for securities of
      specified security holders of the Company, by such holders;

                                       4
<PAGE>

                  (ii) second, the Warrant Shares held by the Holder and all
      other holders of Common Stock entitled to be included in such registration
      statement (pro rata among the Holder and holders requesting such
      registration based upon the number of shares of Common Stock and Warrant
      Shares requested by each such holder to be registered).

      Notwithstanding the provisions of this Section 11(a), the Company shall
have the right at any time after it shall have given written notice pursuant to
this Section 11(a) (irrespective of whether a written request for inclusion of
any such Warrant Shares shall have been made) to elect not to file any such
proposed registration statement or to withdraw the same after the filing but
prior to the effective date thereof.

            (b) Covenants of the Company with Respect to Registration. In
connection with any registration under Section 11(a) hereof, the Company
covenants and agrees as follows:

                  (i) In connection with the Company's intention to file a
      registration statement, the Company shall use its best efforts to have any
      registration statement declared effective at the earliest possible time
      and shall furnish each Holder such number of prospectuses as shall
      reasonably be requested by such Holder.

                  (ii) The Company shall pay all costs, fees and expenses in
      connection with all registration statements filed pursuant to Section
      11(a) hereof (excluding fees and expenses of Holder's counsel and
      accountants and any underwriting or selling commissions) including,
      without limitation, the Company's legal and accounting fees, printing
      expenses, blue sky fees and expenses.

                  (iii) The Company will take all necessary action which may be
      required in qualifying or registering the Warrant Shares included in a
      registration statement for offering and sale under the securities or blue
      sky laws of such states as reasonably are requested by the Holder,
      provided, that, the Company shall not be obligated to qualify generally to
      do business in any jurisdiction where it is not then so qualified or to
      take any action which would subject it to general service of process or to
      taxation in any jurisdiction where it is not then so subject.

                  (iv) The Company shall furnish without charge to each Holder
      of Warrant Shares, promptly after filing thereof with the Commission, at
      least one copy of the registration statement filed pursuant to Section
      11(a) (a "Registration Statement") and each amendment thereto or each
      amendment or supplement to the prospectus included therein (the
      "Prospectus") including all financial statements and schedules, documents
      incorporated by reference therein and if the Holder so requests in
      writing, all exhibits thereto.

                  (v) The Company shall take such action as may be reasonably
      necessary so that (1) the Registration Statement and any amendment thereto
      and any Prospectus forming a part thereof and any supplement or amendment
      thereto complies in all material respects with the Act and the rules and
      regulations thereunder, (2) the Registration Statement and any amendment
      thereto (in either case, other than with respect to written information
      furnished to the Company by or on behalf of any Holder specifically for
      inclusion therein) does not contain an untrue statement of a material fact
      or omit to state a

                                       5
<PAGE>

      material fact required to be stated therein or necessary to make any
      statement therein not misleading and (3) the Prospectus and any supplement
      thereto (in either case, other than with respect to information from
      Holders as described above), does not include an untrue statement of a
      material fact or omit to state a material fact necessary in order to make
      the statements therein, in light of the circumstances under which they
      were made, not misleading.

                  (vi) The Company shall promptly advise the Holder of Warrant
      Shares registered under the Registration Statement (which advice pursuant
      to clauses (ii) - (iv) shall be accompanied by an instruction to suspend
      the use of the Prospectus until the requisite changes have been made) and,
      if requested by such persons, shall confirm such advice in writing:

                  (1) when the Registration Statement and any amendment thereto
            has been filed with the Commission and when the Registration
            Statement or any post-effective amendment thereto has become
            effective;

                  (2) of any request by the Commission for amendments to the
            Registration Statement or amendments or supplements to the
            Prospectus or for additional information relating thereto;

                  (3) of the issuance by the Commission of any stop order
            suspending the effectiveness of the Registration Statement or of the
            suspension by any state securities commission of the qualification
            of the Warrant Shares for offering or sale in any jurisdiction, or
            the initiation of any proceeding for any of the preceding purposes;
            and

                  (4) of the happening of any event that requires the making of
            any changes in the Prospectus so that, as of such date, the
            Prospectus does not contain an untrue statement of a material fact
            and does not omit to state a material fact required to be stated
            therein or necessary to make the statements therein, in light of the
            circumstances under which they were made, not misleading.

                  (vii) If at any time the Commission shall issue any stop order
      suspending the effectiveness of the Registration Statement, or any state
      securities commission or other regulatory authority shall issue an order
      suspending the qualification or exemption from qualification of the
      Warrant Shares under state securities or Blue Sky laws, the Company shall
      use its reasonable best efforts to obtain the withdrawal or lifting of
      such order at the earliest possible time.

                  (viii) The Company shall, during the period the Company is
      obligated to maintain the effectiveness of a Registration Statement under
      Section 11(b) hereof, deliver to each Holder of Warrant Shares included
      under the Registration Statement, without charge, such reasonable number
      of copies of the Prospectus (including each preliminary prospectus)
      included in the Registration Statement and any amendment or supplement
      thereto as such Holder may reasonably request to facilitate the public
      sale or other disposition of the Warrant Shares by the selling Holder.

                                       6
<PAGE>

                  (ix) The Company shall cooperate with the Holder to facilitate
      the timely preparation and delivery of certificates representing Warrant
      Shares to be sold under the Registration Statement, free of any
      restrictive legends and in such denominations and registered in such names
      as the Holder may reasonably request in connection with the sales of
      Warrant Shares pursuant to the Registration Statement.

                  (x) Upon the occurrence of any event contemplated by Section
      11(b)(vi)(2) -- (4) hereof or any request by the Commission for any
      amendments to the Registration Statement or for additional information
      relating thereto or the happening of any event that requires the making of
      any changes in the Registration Statement, the Company shall file (and use
      its reasonable best efforts to have declared effective as soon as
      possible) a post-effective amendment to the Registration Statement or an
      amendment or supplement to the Prospectus or file any other required
      document so that, as thereafter delivered to the purchasers of Warrant
      Shares registered under the Registration Statement, the Prospectus will
      not contain an untrue statement of a material fact or omit to state any
      material fact necessary to make the statements therein in light of the
      circumstances under which they were made not misleading. Each Holder of
      Warrant Shares registered under the Registration Statement agrees by
      acquisition of such Warrant Shares that, upon receipt of any notice from
      the Company of the existence of any fact of the kind described in Section
      11(b)(vi)(2) -- (4) hereof, such Holder will forthwith discontinue
      disposition of Warrant Shares pursuant to the Registration Statement until
      such Holder receives copies of the supplemented or amended Prospectus
      contemplated by this Section 11(b)(x), or until such Holder is advised in
      writing by the Company that the use of the Prospectus may be resumed, and
      such Holder has received copies of any additional or supplemental filings
      which are incorporated by reference in the Prospectus. If so directed by
      the Company, each Holder will deliver to the Company (at the Company's
      expense) all copies, other than permanent file copies then in such
      Holder's possession, of the Prospectus covering such Warrant Shares
      current at the time of receipt of such notice.

                  (xi) Nothing contained in this Agreement shall be construed as
      requiring the Holder to exercise their Warrants prior to the initial
      filing of any registration statement or the effectiveness thereof.

                  (xii) The Company shall furnish to each Holder participating
      in the offering and to each Holder, if any, a signed counterpart,
      addressed to such Holder or Holder, of (1) an opinion of counsel to the
      Company, dated the effective date of such Registration Statement (and, if
      such registration includes an underwritten public offering, an opinion
      dated the date of the closing under the underwriting agreement), and (2)
      if and to the extent permitted by Statement of Auditing Standards No. 72,
      a "cold comfort" letter dated the effective date of such Registration
      Statement (and, if such registration includes an underwritten public
      offering, a letter dated the date of the closing under the underwriting
      agreement) signed by the independent public accountants who have issued a
      report on the Company's financial statements included in such Registration
      Statement, in each case covering substantially the same matters with
      respect to such Registration Statement (and the prospectus included
      therein) and, in the case of such accountants' letter, with respect to
      events subsequent to the date of such financial statements, as are
      customarily covered in

                                       7
<PAGE>

      opinions of issuer's counsel and in accountants' letters delivered to
      Holders in underwritten public offerings of securities.

                  (xiii) The Company shall as soon as practicable after the
      effective date of the Registration Statement, and in any event within 15
      months thereafter, make "generally available to its security holders"
      (within the meaning of Rule 158 of the General Rules and Regulations under
      the Act) an earnings statement (which need not be audited) complying with
      Section 12(a) of the Act and covering a period of at least 12 consecutive
      months beginning after the effective date of the Registration Statement.

                  (xiv) The Company shall deliver promptly to each Holder
      participating in the offering upon request, copies of all correspondence
      between the Commission and the Company, its counsel or accountants and all
      memoranda relating to discussions with the Commission or its staff with
      respect to the Registration Statement and shall permit each Holder and
      such Holders to do such investigation, upon reasonable advance notice,
      with respect to information contained in or omitted from the Registration
      Statement as it deems reasonably necessary to comply with applicable
      securities laws or rules of the NASD. Such investigation shall include
      access to books, records and properties and opportunities to discuss the
      business of the Company with its officers and independent accountants, all
      to such reasonable extent and at such reasonable times and as often as any
      Holder shall reasonably request.

                  (xv) In addition to Warrant Shares, upon the written request
      therefor by any Holders, the Company shall include in the Registration
      Statement any other securities of the Company held by such Holder as of
      the date of filing of such Registration Statement, including, without
      limitation, restricted shares of Common Stock, options, warrants or
      securities convertible into shares of Common Stock and shall not be
      requested by the Company to provide indemnification except as provided in
      Section 11(b)(xvii) hereof.

                  (xvi) For purposes of this Agreement, wherever a specified
      percent of Holders is required to take action, such percentage shall be
      calculated: (1) assuming the immediate exercise of all of the outstanding
      Warrants for Common Stock and (2) excluding the shares of Common Stock
      then issued or issuable pursuant to Warrants that (x) are held by the
      Company, an affiliate or officer thereof or any of their respective
      affiliates, members of their family or persons acting as their nominees or
      in conjunction therewith or (y) have been resold to the public pursuant to
      a Registration Statement filed with the Commission under the Act.

                  (xvii) Indemnification and Contribution.

                  (1) The Company agrees to indemnify and hold harmless each
            Holder (for purposes of this Section 11(b)(xvii), "Holder" shall
            include the officers, directors, partners, employees and agents, and
            each person, if any, who controls or is controlled by any Holder
            ("controlling person") within the meaning of Section 15 of the Act
            or Section 20(a) of the Exchange Act of 1934, as amended (the
            "Exchange Act"), from and against any and all losses, claims,
            damages, expenses or liabilities, joint or several (and actions,
            proceedings, suits and litigation in respect thereof), whatsoever,
            as the same are incurred, to which such Holder or any such

                                       8
<PAGE>

            controlling person may become subject, under the Act, the Exchange
            Act or any other statute or at common law or otherwise insofar as
            such losses, claims, damages, expenses or liabilities arise out of
            or are based upon any untrue statement or alleged untrue statement
            of a material fact contained in the Registration Statement, or any
            preliminary Prospectus or Prospectus (as from time to time amended
            and supplemented) or arise out of or are based upon the omission or
            alleged omission therefrom of a material fact required to be stated
            therein or necessary to make the statements therein (with respect to
            any preliminary Prospectus or Prospectus, in the light of the
            circumstances under which they were made), not misleading; provided,
            however, that the Company shall not be liable in any such case to
            the extent that any such loss, claim, damage, expense or liability
            arises out of or is based upon any untrue statement or alleged
            untrue statement or omission or alleged omission made in the
            Registration Statement, or any preliminary Prospectus or Prospectus
            or any such amendment or supplement in reliance upon and in
            conformity with written information furnished to the Company by or
            on behalf of Holder specifically for inclusion therein and provided,
            further, that the Company shall not be liable to any such Holder
            under the indemnity agreement in this subsection (1): (i) with
            respect to any preliminary Prospectus or Prospectus (if such
            Prospectus has then been amended or supplemented) to the extent that
            any such loss, liability, claim, damage or expense of such Holder
            arises out of a sale of Warrant Shares by such Holder to a person to
            whom (a) there was not sent or given, at or prior to the written
            confirmation of such sale, a copy of the Prospectus (or of the
            Prospectus as then amended or supplemented) if the Company has
            previously furnished copies thereof to such Holder a reasonable time
            in advance or (b) prior to written confirmation of such sale, such
            Holder received notice from the Company pursuant to Section 11(b)(x)
            to discontinue disposition pursuant to such Prospectus and, in
            either case, the loss, liability, claim, damage or expense of such
            Holder results from an untrue statement or alleged untrue statement
            or omission or alleged omission of a material fact contained in the
            preliminary Prospectus (or the Prospectus) which was corrected in
            the Prospectus (or the Prospectus as amended or supplemented) or
            (ii) to the extent that any such loss, claim, damage, expense or
            liability arises out of or is based upon any action or failure to
            act by such Holder that is found in a final judicial determination
            (or a settlement tantamount thereto to which such Holder has given
            its prior written consent) to constitute bad faith, willful
            misconduct or gross negligence on the part of such Holder. The
            indemnity agreement in this subsection (1) shall be in addition to
            any liability which the Company may have at common law or otherwise,
            to the extent not inconsistent therewith.

                  (2) Each Holder agrees to indemnify and hold harmless the
            Company, each of its directors, each of its officers and each other
            person, if any, who controls the Company within the meaning of the
            Act, to the same extent as the foregoing indemnity from the Company
            to the Holders, but only with respect to (i) statements or
            omissions, if any, made in conformity with information relating to
            such Holder furnished in writing by or on behalf of such Holder
            specifically for use in the Registration Statement, or any
            preliminary Prospectus or the Prospectus or any amendment thereof or
            supplement thereto, and (ii) any breach of such Holder's

                                       9
<PAGE>

            representations, covenants or agreements set forth herein; provided,
            however, that the obligation to indemnify will be individual to each
            Holder and will be limited to the amount of net proceeds received by
            such Holder from the sale of Warrant Shares pursuant to the
            Registration Statement.

                  (3) Promptly after receipt by an indemnified party under this
            Section 11(b)(xvii) of notice of the commencement of any action,
            suit or proceeding, such indemnified party shall, if a claim in
            respect thereof is to be made against one or more indemnifying
            parties under this Section 11(b)(xvii), notify each party against
            whom indemnification is to be sought in writing of the commencement
            thereof (but the failure to notify an indemnifying party shall not
            relieve it from any liability which it may have under Sections
            11(b)(xvii)(l) or (2) unless and to the extent that it has been
            prejudiced in a material respect by such failure or from the
            forfeiture of substantial rights and defenses). In case any such
            action, suit or proceeding is brought against any indemnified party,
            and it notifies an indemnifying party or parties of the commencement
            thereof, the indemnifying party or parties will be entitled to
            participate therein, and to the extent it may elect by written
            notice delivered to the indemnified party promptly after receiving
            the aforesaid notice from such indemnified party, to assume the
            defense thereof with counsel reasonably satisfactory to such
            indemnified party, which may be the same counsel as counsel to the
            indemnifying party. Notwithstanding the foregoing, the indemnified
            party or parties shall have the right to employ its or their own
            counsel in any such case but the fees and expenses of such counsel
            shall be at the expense of such indemnified party or parties unless
            (i) the employment of such counsel shall have been authorized in
            writing by the indemnifying parties in connection with the defense
            of such action at the expense of the indemnifying party, (ii) the
            indemnifying parties shall not have employed counsel reasonably
            satisfactory to such indemnified party to take charge of the defense
            of such action within a reasonable time after notice of commencement
            of the action or (iii) such indemnified party or parties shall have
            reasonably concluded, after consultation with counsel to such
            indemnified party or parties, that a conflict of interest exists
            which makes representation by counsel chosen by the indemnifying
            party not advisable (in which case the indemnifying parties shall
            not have the right to direct the defense of such action on behalf of
            the indemnified party or parties), in any of which events such fees
            and expenses of one additional counsel shall be borne by the
            indemnifying parties. In no event shall the indemnifying parties be
            liable for fees and expenses of more than one counsel (in addition
            to any local counsel) separate from their own counsel for all
            indemnified parties in connection with any one action or separate
            but similar or related actions in the same jurisdiction arising out
            of the same general allegations or circumstances. Anything in this
            Section 11(b)(xvii) to the contrary notwithstanding, an indemnifying
            party shall not be liable for any settlement of any claim or action
            effected without its written consent, which shall not be
            unreasonably withheld or delayed.

                  (4) In order to provide for just and equitable contribution in
            any case in which (i) an indemnified party makes claim for
            indemnification pursuant to this Section 11(b)(xvii), but it is
            judicially determined (by the entry of a final judgment

                                       10
<PAGE>

            or decree by a court of competent jurisdiction and the expiration of
            time to appeal or the denial of the last right of appeal) that such
            indemnification may not be enforced in such case notwithstanding the
            fact that the express provisions of this Section 11(b)(xvii) provide
            for indemnification in such case, or (ii) contribution under the Act
            may be required, then each indemnifying party, in lieu of
            indemnifying such indemnified party, shall contribute to the amount
            paid as a result of such losses, claims, damages, expenses or
            liabilities (or actions, suits, proceedings or litigation in respect
            thereof) in such proportion as is appropriate to reflect the
            relative fault of each of the contributing parties, on the one hand,
            and the party to be indemnified, on the other hand, in connection
            with the statements or omissions that resulted in such losses,
            claims, damages, expenses or liabilities, as well as any other
            relevant equitable considerations. Relative fault shall be
            determined by reference to, among other things, whether the untrue
            or alleged untrue statement of a material fact or the omission or
            alleged omission to state a material fact relates to information
            supplied by the Company or by the Holder, and the parties' relative
            intent, knowledge, access to information and opportunity to correct
            or prevent such untrue statement or omission. The amount paid or
            payable by an indemnified party as a result of the losses, claims,
            damages, expenses or liabilities (or actions, suits, proceedings or
            litigation in respect thereof) referred to above in this subsection
            (4) shall be deemed to include any legal or other expenses
            reasonably incurred by such indemnified party in connection with
            investigating, preparing or defending any such action, claim, suit,
            proceeding or litigation. Notwithstanding the provisions of this
            subsection (4), no Holder shall be required to contribute any amount
            in excess of the amount by which the total price at which the
            Warrant Shares sold by such Holder as the indemnifying party and
            distributed to the public were offered to the public exceeds the
            amount of any damages that such indemnifying party has otherwise
            been required to pay by reason of such untrue or alleged untrue
            statement or omission or alleged omission. No person guilty of
            fraudulent misrepresentation or omission (within the meaning of
            Section 12(a)(2) of the Act) shall be entitled to contribution from
            any person who was not guilty of such fraudulent misrepresentation
            or omission. For purposes of this Section 11(b)(xvii), each person,
            if any, who controls the Company within the meaning of the Act, each
            executive officer of the Company and each director of the Company
            shall have the same rights to contribution as the Company, subject
            in each case to this subsection (4). Any party entitled to
            contribution shall, promptly after receipt of notice of commencement
            of any action, suit, proceeding or litigation against such party in
            respect to which a claim for contribution may be made against
            another party or parties under this subsection (4), notify such
            party or parties from whom contribution may be sought, but the
            omission so to notify such party or parties shall not relieve the
            party or parties from whom contribution may be sought from any
            obligation it or they may have hereunder or otherwise than under
            this subsection (4), or to the extent that such party or parties
            were not adversely affected by such omission. The contribution
            agreement set forth above shall be in addition to any liabilities
            which any indemnifying party may have at common law or otherwise.

                  (xviii) Notwithstanding the foregoing provisions of this
      Section 11(b), no registration rights shall be extended pursuant to this
      Section 11 with respect to any Warrant

                                       11
<PAGE>

      Shares (i) which have been sold pursuant to and in accordance with an
      effective Registration Statement, (ii) sold in accordance with Rule 144
      under the Act or (iii) eligible for sale under Rule 144(k) under the Act.

      12. Miscellaneous.

            (a) All notices or demands shall be in writing and shall be
delivered personally, electronically, or by express, certified or registered
mail or by private overnight express mail service. Delivery shall be deemed
conclusively made (i) at the time of delivery if personally delivered, (ii)
immediately in the event notice is delivered by confirmed facsimile, (iii)
twenty-four (24) hours after delivery to the carrier if served by any private,
overnight express mail service, (iv) twenty-four (24) hours after deposit
thereof in the United States mail, properly addressed and postage prepaid,
return receipt requested, if served by express mail, or (v) five (5) days after
deposit thereof in the United States mail, properly addressed and postage
prepaid, return receipt requested, if served by certified or registered mail.

      Any notice or demand to the Company shall be given to:

            SinoFresh HealthCare, Inc.
            516 Paul Morris Drive
            Englewood, Florida   34223
            Attention:  Chief Financial Officer

      Any notice or demand to Holder shall be given to:

            Bristol Investment Partners I
            135 East 57th Street, 15th Floor
            New York, NY 10022

Any party may, by virtue of written notice in compliance with this paragraph,
alter or change the address or the identity of the person to whom any notice, or
copy thereof, is to be delivered.

            (b) The Holder of this Warrant, by acceptance hereof, agrees that
any controversy arising out of or relating to this Warrant, or the making,
performance or interpretation thereof, including the interpretation and scope of
this arbitration provision, claims arising thereunder or relating thereto, and
any claims involving statements, agreements or representations made during the
negotiation of this Warrant, shall be settled by final and binding arbitration
in accordance with the Commercial Arbitration rules of the American Arbitration
Association, before three arbitrators of whom at least one shall be a certified
public accountant and one shall be an attorney, each with at least ten years of
practice in their respective fields.

            (c) The Company and the Holder shall each execute and deliver all
such further instruments, documents and papers, and shall perform any and all
acts necessary, to give full force and effect to all of the terms and provisions
of this Warrant.

            (d) This Warrant shall inure to the benefit of and be binding upon
the parties hereto, and their successors in interest.

                                       12
<PAGE>

            (e) This Warrant incorporates the entire understanding of the
parties and supersedes all previous agreements relating to the subject matter
hereof should they exist. This Warrant and any issue arising out of or relating
to the parties relationship hereunder shall be governed by, and construed in
accordance with, the laws of the State of Washington, without regard to
principles of conflicts of law. In all matters of interpretation, whenever
necessary to give effect to any provision of this Warrant, each gender shall
include the others, the singular shall include the plural, and the plural shall
include the singular. The titles of the paragraphs of this Warrant are for
convenience only and shall not in any way affect the interpretation of any
provision or condition of this Warrant.

            (f) In the event of any litigation or arbitration between the
parties hereto respecting or arising out of this Warrant, the prevailing party
shall be entitled to recover reasonable legal fees, whether or not such
litigation or arbitration proceeds to final judgment or determination.

            (g) Jurisdiction and Venue. Each party hereto consents specifically
to the exclusive jurisdiction of the federal courts of the United States sitting
in the Eastern District of Florida, or if such federal court declines to
exercise jurisdiction over any action filed pursuant to this Warrant, the courts
of the State of Florida sitting in the County of Sarasota, and any court to
which an appeal may be taken in connection with any action filed pursuant to
this Warrant, for the purposes of all legal proceedings arising out of or
relating to this Warrant. In connection with the foregoing consent, each party
irrevocably waives, to the fullest extent permitted by law, any objection which
it may now or hereafter have to the court's exercise of personal jurisdiction
over each party to this Warrant or the laying of venue of any such proceeding
brought in such a court and any claim that any such proceeding brought in such a
court has been brought in an inconvenient forum. Each party further irrevocably
waives its right to a trial by jury and consents that service of process may be
effected in any manner permitted under the laws of the State of Florida.

            (h) If any clause or provision of this Warrant is illegal, invalid
or unenforceable under present or future laws effective during the term of this
Warrant, then and, in that event, the remainder of this Warrant shall not be
affected thereby, and in lieu of each clause or provision of this Warrant that
is illegal, invalid or unenforceable, there shall be added a clause or provision
as similar in terms and in amount to such illegal, invalid or unenforceable
clause or provision as may be possible and be legal, valid and enforceable, as
long as it does not otherwise frustrate the principal purposes of this Warrant.

      IN WITNESS WHEREOF, SinoFresh HealthCare, Inc., has caused this Warrant to
be executed by its officers thereunto duly authorized.

SINOFRESH HEALTHCARE, INC.

By: /s/ Charles A. Fust                                    Date: January 5, 2005
    Charles A. Fust
    Chairman and Chief Executive Officer

                                       13
<PAGE>

                                   EXHIBIT "A"

                               NOTICE OF EXERCISE

                (To be signed only upon exercise of the Warrant)

TO:  SinoFresh HealthCare, Inc.

The undersigned, hereby irrevocably elects to exercise the purchase rights
represented by the Warrant granted to the undersigned on ______________ and to
purchase thereunder 8,000 shares of Common Stock of SinoFresh HealthCare, Inc.
(the "Company") and herewith encloses either payment of $8,000.00 or
instructions regarding the manner of exercise permitted under Section 3(b) of
the Warrant, in full payment of the purchase price of such shares being
purchased.

Dated: _________________

                             _____________________________________________
                             (Signature must conform in all respects to name of
                             holder as specified on the face of the Warrant)

                             _____________________________________________
                             (Please Print Name)

                             _____________________________________________
                             (Address)

                                       14<PAGE>

                                                                    EXHIBIT 4.17

THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS
OTHERWISE SET FORTH HEREIN, NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE
SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR SUCH SECURITIES UNDER SAID ACT OR, AN OPINION OF COUNSEL, IN FORM,
SUBSTANCE AND SCOPE, CUSTOMARY FOR OPINIONS OF COUNSEL IN COMPARABLE
TRANSACTIONS, WHICH OPINION SHALL HAVE BEEN ACCEPTED BY THE ISSUER, THAT
REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144
OR REGULATION S UNDER SUCH ACT.

                             STOCK PURCHASE WARRANT

      THIS CERTIFIES THAT, for value received, BRISTOL INVESTMENT PARTNERS LP I,
or its registered assigns, is entitled to purchase from SinoFresh HealthCare,
Inc., a Florida corporation (the "COMPANY"), at any time or from time to time
during the period specified in Section 2 hereof, Two Hundred Eighty-Eight
Thousand (288,000) fully paid and nonassessable shares of the Company's Common
Stock, no par value (the "COMMON STOCK"), at an exercise price per share equal
to fifty-five cents ($0.55) (the "EXERCISE PRICE"). The term "WARRANT SHARES,"
as used herein, refers to the shares of Common Stock purchasable hereunder. The
Warrant Shares and the Exercise Price are subject to adjustment as provided in
Section 4 hereof. The term "WARRANTS" means this Warrant and the other warrants
issued pursuant to that certain Securities Purchase Agreement, dated December 6,
2004, by and among the Company and the Buyers listed on the execution page
thereof (the "SECURITIES PURCHASE AGREEMENT").

      This Warrant is issued pursuant to a partial assignment by Bristol
Investment Group, Inc. of a warrant for 320,000 shares of common stock dated as
of December 6, 2004 (the "DATE OF ISSUANCE").

      This Warrant is subject to the following terms, provisions, and
conditions:

      1. MANNER OF EXERCISE.

            (a) PROCEDURE. Subject to the provisions hereof, this Warrant may be
exercised by the holder hereof, in whole or in part, by the surrender of this
Warrant, together with a completed exercise agreement in the form attached
hereto (the "EXERCISE AGREEMENT"), to the Company during normal business hours
on any business day at the Company's principal executive offices (or such other
office or agency of the Company as it may designate by notice to the holder
hereof), and upon (i) payment to the Company in cash, by certified or official
bank check or by wire transfer for the account of the Company of the Exercise
Price for the Warrant Shares specified in the Exercise Agreement or (ii)
delivery to the Company of a written notice of an election to effect a Cashless
Exercise (as defined in Section 1(c) below) for the Warrant Shares specified in
the Exercise Agreement. The Warrant Shares so purchased shall be deemed to be
issued to the holder hereof or such holder's designee, as the record owner of
such shares, as of the close of business on the date on which this Warrant shall
have been surrendered, the completed Exercise Agreement shall have been
delivered, and payment shall have been made for such shares as set forth above.
Certificates for the Warrant Shares so purchased, representing the aggregate
number of shares specified in the Exercise Agreement, shall be delivered to the
holder hereof within a reasonable time, not exceeding three (3) business days,
after this Warrant shall have been so exercised. The certificates so delivered
shall be in such denominations as may be requested by the holder hereof and
shall be registered in the name of such holder or such other name as shall be
designated by such holder. If

<PAGE>

this Warrant shall have been exercised only in part, then, unless this Warrant
has expired, the Company shall, at its expense, at the time of delivery of such
certificates, deliver to the holder a new Warrant representing the number of
shares with respect to which this Warrant shall not then have been exercised.

            (b) EXERCISE LIMIT. Notwithstanding anything in this Warrant to the
contrary, in no event shall the holder of this Warrant be entitled to exercise a
number of Warrants (or portions thereof) in excess of the number of Warrants (or
portions thereof) upon exercise of which the sum of (i) the number of shares of
Common Stock beneficially owned by the holder and its affiliates (other than
shares of Common Stock which may be deemed beneficially owned through the
ownership of the unexercised Warrants and the unexercised or unconverted portion
of any other securities of the Company (including the Notes (as defined in the
Securities Purchase Agreement)) subject to a limitation on conversion or
exercise analogous to the limitation contained herein) and (ii) the number of
shares of Common Stock issuable upon exercise of the Warrants (or portions
thereof) with respect to which the determination described herein is being made,
would result in beneficial ownership by the holder and its affiliates of more
than 4.99% of the outstanding shares of Common Stock. For purposes of the
immediately preceding sentence, beneficial ownership shall be determined in
accordance with Section 13(d) of the Securities Exchange Act of 1934, as
amended, and Regulation 13D-G thereunder, except as otherwise provided in clause
(i) of the preceding sentence. The Holder may waive the provisions of this
Section 1.1(c) as to itself (and solely as to itself) upon not less than 75
days' prior notice to the Borrower, and the provisions of this Section 1.1(c)
shall continue to apply until such 75th day (or such later date as may be
specified in such notice of waiver). No conversion in violation of this Section
1.1(c), but otherwise in accordance with this Debenture, shall affect the status
of the Common Stock issued upon such conversion as validly issued, fully-paid
and nonassessable.

            (c) CASHLESS EXERCISE. Notwithstanding anything to the contrary
contained in this Warrant, this Warrant may be exercised by presentation and
surrender of this Warrant to the Company at its principal executive offices with
a written notice of the holder's intention to effect a cashless exercise,
including a calculation of the number of shares of Common Stock to be issued
upon such exercise in accordance with the terms hereof (a "CASHLESS EXERCISE").
In the event of a Cashless Exercise, in lieu of paying the Exercise Price in
cash, the holder shall surrender this Warrant for that number of shares of
Common Stock determined by multiplying the number of Warrant Shares to which it
would otherwise be entitled by a fraction, the numerator of which shall be the
difference between (i) the average Market Price per share of the Common Stock
for the five (5) Trading Days immediately prior to the date the completed
Exercise Agreement shall have been delivered to the Company (the "CASHLESS
EXERCISE MARKET PRICE") and (ii) the Exercise Price, and the denominator of
which shall be the Cashless Exercise Market Price.

      2. PERIOD OF EXERCISE. This Warrant is exercisable at any time or from
time to time on or after the date on which this Warrant is issued and delivered
pursuant to the terms of the Securities Purchase Agreement and before 6:00 p.m.,
New York, New York time on the fifth (5th) anniversary of the Date of Issuance
(the "EXERCISE PERIOD").

      3. CERTAIN AGREEMENTS OF THE COMPANY. The Company hereby covenants and
agrees as follows:

            (a) SHARES TO BE FULLY PAID. All Warrant Shares will, upon issuance
in accordance with the terms of this Warrant, be validly issued, fully paid, and
nonassessable and free from all taxes, liens, and charges with respect to the
issue thereof.

            (b) RESERVATION OF SHARES. During the Exercise Period, the Company
shall at all times have authorized, and reserved for the purpose of issuance
upon exercise of this Warrant, a sufficient number of shares of Common Stock to
provide for the exercise of this Warrant.

                                       2
<PAGE>

            (c) LISTING. The Company shall promptly secure the listing of the
shares of Common Stock issuable upon exercise of the Warrant upon each national
securities exchange or automated quotation system, if any, upon which shares of
Common Stock are then listed, or, if not so listed, on the NASD Over-the-Counter
Bulletin Board, (subject to official notice of issuance upon exercise of this
Warrant) and shall maintain, so long as any other shares of Common Stock shall
be so listed, such listing of all shares of Common Stock from time to time
issuable upon the exercise of this Warrant; and the Company shall so list on
each national securities exchange or automated quotation system, as the case may
be, and shall maintain such listing of, any other shares of capital stock of the
Company issuable upon the exercise of this Warrant if and so long as any shares
of the same class shall be listed on such national securities exchange or
automated quotation system.

            (d) CERTAIN ACTIONS PROHIBITED. The Company will not, by amendment
of its charter or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms to be
observed or performed by it hereunder, but will at all times in good faith
assist in the carrying out of all the provisions of this Warrant and in the
taking of all such action as may reasonably be requested by the holder of this
Warrant in order to protect the exercise privilege of the holder of this Warrant
against dilution or other impairment, consistent with the tenor and purpose of
this Warrant. Without limiting the generality of the foregoing, the Company (i)
will not increase the par value of any shares of Common Stock receivable upon
the exercise of this Warrant above the Exercise Price then in effect, and (ii)
will take all such actions as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable shares of
Common Stock upon the exercise of this Warrant.

            (e) SUCCESSORS AND ASSIGNS. This Warrant will be binding upon any
entity succeeding to the Company by merger, consolidation, or acquisition of all
or substantially all the Company's assets.

      4. ANTIDILUTION PROVISIONS. During the Exercise Period, the Exercise Price
and the number of Warrant Shares shall be subject to adjustment from time to
time as provided in this Section 4.

      In the event that any adjustment of the Exercise Price as required herein
results in a fraction of a cent, such Exercise Price shall be rounded up to the
nearest cent.

            (a) ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES UPON ISSUANCE
OF COMMON STOCK. Except as otherwise provided in Sections 4(c) and 4(e) hereof,
if and whenever on or after the date of issuance of this Warrant, the Company
issues or sells, or in accordance with Section 4(b) hereof is deemed to have
issued or sold, any shares of Common Stock for no consideration or for a
consideration per share (before deduction of reasonable expenses or commissions
or underwriting discounts or allowances in connection therewith) less than the
Exercise Price on the date of issuance (a "DILUTIVE ISSUANCE"), then immediately
upon the Dilutive Issuance, the Exercise Price will be reduced to a price
determined by multiplying the Exercise Price in effect immediately prior to the
Dilutive Issuance by a fraction, (i) the numerator of which is an amount equal
to the sum of (x) the number of shares of Common Stock actually outstanding
immediately prior to the Dilutive Issuance, plus (y) the quotient of the
aggregate consideration, calculated as set forth in Section 4(b) hereof,
received by the Company upon such Dilutive Issuance divided by the Exercise
Price in effect immediately prior to the Dilutive Issuance, and (ii) the
denominator of which is the total number of shares of Common Stock Deemed
Outstanding (as defined below) immediately after the Dilutive Issuance. If,
however, any Dilutive Issuance occurs at any time during the period commencing
on the date of the Purchase Agreement through the date two (2) years from the
effective date of the Registration Statement as provided in Section 2(a) of the
Registration Rights Agreement, then immediately upon the Dilutive Issuance the
Exercise Price will be reduced to the lower of (i) such price as determined in
the foregoing sentence, or (ii) the amount of the consideration per

                                       3
<PAGE>

share received by the Company in such Dilutive Issuance; provided that only one
adjustment will be made for each Dilutive Issuance.

            (b) EFFECT ON EXERCISE PRICE OF CERTAIN EVENTS. For purposes of
determining the adjusted Exercise Price under Section 4(a) hereof, the following
will be applicable:

                  (i) ISSUANCE OF RIGHTS OR OPTIONS. If the Company in any
manner issues or grants any warrants, rights or options, whether or not
immediately exercisable, to subscribe for or to purchase Common Stock or other
securities convertible into or exchangeable for Common Stock ("CONVERTIBLE
SECURITIES") (such warrants, rights and options to purchase Common Stock or
Convertible Securities are hereinafter referred to as "OPTIONS") and the price
per share for which Common Stock is issuable upon the exercise of such Options
is less than the Exercise Price on the date of issuance or grant of such
Options, then the maximum total number of shares of Common Stock issuable upon
the exercise of all such Options will, as of the date of the issuance or grant
of such Options, be deemed to be outstanding and to have been issued and sold by
the Company for such price per share. For purposes of the preceding sentence,
the "price per share for which Common Stock is issuable upon the exercise of
such Options" is determined by dividing (i) the total amount, if any, received
or receivable by the Company as consideration for the issuance or granting of
all such Options, plus the minimum aggregate amount of additional consideration,
if any, payable to the Company upon the exercise of all such Options, plus, in
the case of Convertible Securities issuable upon the exercise of such Options,
the minimum aggregate amount of additional consideration payable upon the
conversion or exchange thereof at the time such Convertible Securities first
become convertible or exchangeable, by (ii) the maximum total number of shares
of Common Stock issuable upon the exercise of all such Options (assuming full
conversion of Convertible Securities, if applicable). No further adjustment to
the Exercise Price will be made upon the actual issuance of such Common Stock
upon the exercise of such Options or upon the conversion or exchange of
Convertible Securities issuable upon exercise of such Options.

                  (ii) ISSUANCE OF CONVERTIBLE SECURITIES. If the Company in any
manner issues or sells any Convertible Securities, whether or not immediately
convertible (other than where the same are issuable upon the exercise of
Options) and the price per share for which Common Stock is issuable upon such
conversion or exchange is less than the Exercise Price on the date of issuance,
then the maximum total number of shares of Common Stock issuable upon the
conversion or exchange of all such Convertible Securities will, as of the date
of the issuance of such Convertible Securities, be deemed to be outstanding and
to have been issued and sold by the Company for such price per share. For the
purposes of the preceding sentence, the "price per share for which Common Stock
is issuable upon such conversion or exchange" is determined by dividing (i) the
total amount, if any, received or receivable by the Company as consideration for
the issuance or sale of all such Convertible Securities, plus the minimum
aggregate amount of additional consideration, if any, payable to the Company
upon the conversion or exchange thereof at the time such Convertible Securities
first become convertible or exchangeable, by (ii) the maximum total number of
shares of Common Stock issuable upon the conversion or exchange of all such
Convertible Securities. No further adjustment to the Exercise Price will be made
upon the actual issuance of such Common Stock upon conversion or exchange of
such Convertible Securities.

                  (iii) CHANGE IN OPTION PRICE OR CONVERSION RATE. If there is a
change at any time in (i) the amount of additional consideration payable to the
Company upon the exercise of any Options; (ii) the amount of additional
consideration, if any, payable to the Company upon the conversion or exchange of
any Convertible Securities; or (iii) the rate at which any Convertible
Securities are convertible into or exchangeable for Common Stock (other than
under or by reason of provisions designed to protect against dilution), the
Exercise Price in effect at the time of such change will be readjusted to the
Exercise Price which would have been in effect at such time had such Options or

                                       4
<PAGE>

Convertible Securities still outstanding provided for such changed additional
consideration or changed conversion rate, as the case may be, at the time
initially granted, issued or sold.

                  (iv) TREATMENT OF EXPIRED OPTIONS AND UNEXERCISED CONVERTIBLE
SECURITIES. If, in any case, the total number of shares of Common Stock issuable
upon exercise of any Option or upon conversion or exchange of any Convertible
Securities is not, in fact, issued and the rights to exercise such Option or to
convert or exchange such Convertible Securities shall have expired or
terminated, the Exercise Price then in effect will be readjusted to the Exercise
Price which would have been in effect at the time of such expiration or
termination had such Option or Convertible Securities, to the extent outstanding
immediately prior to such expiration or termination (other than in respect of
the actual number of shares of Common Stock issued upon exercise or conversion
thereof), never been issued.

                  (v) CALCULATION OF CONSIDERATION RECEIVED. If any Common
Stock, Options or Convertible Securities are issued, granted or sold for cash,
the consideration received therefor for purposes of this Warrant will be the
amount received by the Company therefor, before deduction of reasonable
commissions, underwriting discounts or allowances or other reasonable expenses
paid or incurred by the Company in connection with such issuance, grant or sale.
In case any Common Stock, Options or Convertible Securities are issued or sold
for a consideration part or all of which shall be other than cash, the amount of
the consideration other than cash received by the Company will be the fair value
of such consideration, except where such consideration consists of securities,
in which case the amount of consideration received by the Company will be the
average Market Price per share of the Common Stock for the five (5) Trading Days
immediately prior to the date of receipt. In case any Common Stock, Options or
Convertible Securities are issued in connection with any acquisition, merger or
consolidation in which the Company is the surviving corporation, the amount of
consideration therefor will be deemed to be the fair value of such portion of
the net assets and business of the non-surviving corporation as is attributable
to such Common Stock, Options or Convertible Securities, as the case may be. The
fair value of any consideration other than cash or securities will be determined
in good faith by the Board of Directors of the Company.

                  (vi) EXCEPTIONS TO ADJUSTMENT OF EXERCISE PRICE. No adjustment
to the Exercise Price will be made (i) upon the exercise of any warrants,
options or convertible securities granted, issued and outstanding on the date of
issuance of this Warrant or any Warrants issued pursuant to the Securities
Purchase Agreement; (ii) upon the grant or exercise of any stock or options
which may hereafter be granted or exercised under any employee benefit plan,
stock option plan or restricted stock plan of the Company now existing or to be
implemented in the future, so long as the issuance of such stock or options is
not to any executive officer, director or any of their affiliates; or (iii) upon
the exercise of the Warrants.

            (c) SUBDIVISION OR COMBINATION OF COMMON STOCK. If the Company at
any time subdivides (by any stock split, stock dividend, recapitalization,
reorganization, reclassification or otherwise) the shares of Common Stock
acquirable hereunder into a greater number of shares, then, after the date of
record for effecting such subdivision, the Exercise Price in effect immediately
prior to such subdivision will be proportionately reduced. If the Company at any
time combines (by reverse stock split, recapitalization, reorganization,
reclassification or otherwise) the shares of Common Stock acquirable hereunder
into a smaller number of shares, then, after the date of record for effecting
such combination, the Exercise Price in effect immediately prior to such
combination will be proportionately increased.

            (d) ADJUSTMENT IN NUMBER OF SHARES. Upon each adjustment of the
Exercise Price pursuant to the provisions of this Section 4, the number of
shares of Common Stock issuable upon

                                       5
<PAGE>

exercise of this Warrant shall be adjusted by multiplying a number equal to the
Exercise Price in effect immediately prior to such adjustment by the number of
shares of Common Stock issuable upon exercise of this Warrant immediately prior
to such adjustment and dividing the product so obtained by the adjusted Exercise
Price.

            (e) CONSOLIDATION, MERGER OR SALE. In case of any consolidation of
the Company with, or merger of the Company into any other corporation, or in
case of any sale or conveyance of all or substantially all of the assets of the
Company other than in connection with a plan of complete liquidation of the
Company, then as a condition of such consolidation, merger or sale or
conveyance, adequate provision will be made whereby the holder of this Warrant
will have the right to acquire and receive upon exercise of this Warrant in lieu
of the shares of Common Stock immediately theretofore acquirable upon the
exercise of this Warrant, such shares of stock, securities or assets as may be
issued or payable with respect to or in exchange for the number of shares of
Common Stock immediately theretofore acquirable and receivable upon exercise of
this Warrant had such consolidation, merger or sale or conveyance not taken
place. In any such case, the Company will make appropriate provision to insure
that the provisions of this Section 4 hereof will thereafter be applicable as
nearly as may be in relation to any shares of stock or securities thereafter
deliverable upon the exercise of this Warrant. The Company will not effect any
consolidation, merger or sale or conveyance unless prior to the consummation
thereof, the successor corporation (if other than the Company) assumes by
written instrument the obligations under this Section 4 and the obligations to
deliver to the holder of this Warrant such shares of stock, securities or assets
as, in accordance with the foregoing provisions, the holder may be entitled to
acquire.

            (f) DISTRIBUTION OF ASSETS. In case the Company shall declare or
make any distribution of its assets (including cash) to holders of Common Stock
as a partial liquidating dividend, by way of return of capital or otherwise,
then, after the date of record for determining shareholders entitled to such
distribution, but prior to the date of distribution, the holder of this Warrant
shall be entitled upon exercise of this Warrant for the purchase of any or all
of the shares of Common Stock subject hereto, to receive the amount of such
assets which would have been payable to the holder had such holder been the
holder of such shares of Common Stock on the record date for the determination
of shareholders entitled to such distribution.

           (g) NOTICE OF ADJUSTMENT. Upon the occurrence of any event which
requires any adjustment of the Exercise Price, then, and in each such case, the
Company shall give notice thereof to the holder of this Warrant, which notice
shall state the Exercise Price resulting from such adjustment and the increase
or decrease in the number of Warrant Shares purchasable at such price upon
exercise, setting forth in reasonable detail the method of calculation and the
facts upon which such calculation is based. Such calculation shall be certified
by the Chief Financial Officer of the Company.

            (h) MINIMUM ADJUSTMENT OF EXERCISE PRICE. No adjustment of the
Exercise Price shall be made in an amount of less than 1% of the Exercise Price
in effect at the time such adjustment is otherwise required to be made, but any
such lesser adjustment shall be carried forward and shall be made at the time
and together with the next subsequent adjustment which, together with any
adjustments so carried forward, shall amount to not less than 1% of such
Exercise Price.

            (i) NO FRACTIONAL SHARES. No fractional shares of Common Stock are
to be issued upon the exercise of this Warrant, but the Company shall pay a cash
adjustment in respect of any fractional share which would otherwise be issuable
in an amount equal to the same fraction of the average Market Price per share of
the Common Stock for the five (5) Trading Days immediately prior to the date of
such exercise.

                                       6
<PAGE>

            (j) OTHER NOTICES. In case at any time:

                  (i) the Company shall declare any dividend upon the Common
Stock payable in shares of stock of any class or make any other distribution
(including dividends or distributions payable in cash out of retained earnings)
to the holders of the Common Stock;

                  (ii) the Company shall offer for subscription pro rata to the
holders of the Common Stock any additional shares of stock of any class or other
rights;

                  (iii) there shall be any capital reorganization of the
Company, or reclassification of the Common Stock, or consolidation or merger of
the Company with or into, or sale of all or substantially all its assets to,
another corporation or entity; or

                  (iv) there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Company;

then, in each such case, the Company shall give to the holder of this Warrant
(a) notice of the date on which the books of the Company shall close or a record
shall be taken for determining the holders of Common Stock entitled to receive
any such dividend, distribution, or subscription rights or for determining the
holders of Common Stock entitled to vote in respect of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or
winding-up and (b) in the case of any such reorganization, reclassification,
consolidation, merger, sale, dissolution, liquidation or winding-up, notice of
the date (or, if not then known, a reasonable approximation thereof by the
Company) when the same shall take place. Such notice shall also specify the date
on which the holders of Common Stock shall be entitled to receive such dividend,
distribution, or subscription rights or to exchange their Common Stock for stock
or other securities or property deliverable upon such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation, or
winding-up, as the case may be. Such notice shall be given at least 30 days
prior to the record date or the date on which the Company's books are closed in
respect thereto. Failure to give any such notice or any defect therein shall not
affect the validity of the proceedings referred to in clauses (i), (ii), (iii)
and (iv) above.

            (k) CERTAIN EVENTS. If any event occurs of the type contemplated by
the adjustment provisions of this Section 4 but not expressly provided for by
such provisions, the Company will give notice of such event as provided in
Section 4(g) hereof, and the Company's Board of Directors will make an
appropriate adjustment in the Exercise Price and the number of shares of Common
Stock acquirable upon exercise of this Warrant so that the rights of the holder
shall be neither enhanced nor diminished by such event.

            (l) CERTAIN DEFINITIONS.

                  (i) "COMMON STOCK DEEMED OUTSTANDING" shall mean the number of
shares of Common Stock actually outstanding (not including shares of Common
Stock held in the treasury of the Company), plus (x) pursuant to Section 4(b)(i)
hereof, the maximum total number of shares of Common Stock issuable upon the
exercise of Options, as of the date of such issuance or grant of such Options,
if any, and (y) pursuant to Section 4(b)(ii) hereof, the maximum total number of
shares of Common Stock issuable upon conversion or exchange of Convertible
Securities, as of the date of issuance of such Convertible Securities, if any.

                  (ii) "MARKET PRICE" means, as of any Trading Day, (i) the
closing bid price for the shares of Common Stock on the OTCBB as reported by
Bloomberg, or (ii) if the OTCBB is not the principal trading market for the
shares of Common Stock, the closing bid price on the principal

                                       7
<PAGE>

trading market for the Common Stock as reported by Bloomberg, or (iii) if market
value cannot be calculated as of such date on any of the foregoing bases, the
Market Price shall be the fair market value as reasonably determined in good
faith by (a) the Board of Directors of the Company or, at the option of a
majority-in-interest of the holders of the outstanding Warrants by (b) an
independent investment bank of nationally recognized standing in the valuation
of businesses similar to the business of the corporation. The manner of
determining the Market Price of the Common Stock set forth in the foregoing
definition shall apply with respect to any other security in respect of which a
determination as to market value must be made hereunder.

                  (iii) "COMMON STOCK," for purposes of this Section 4, includes
the Common Stock, no par value, and any additional class of stock of the Company
having no preference as to dividends or distributions on liquidation, provided
that the shares purchasable pursuant to this Warrant shall include only shares
of Common Stock, no par value, in respect of which this Warrant is exercisable,
or shares resulting from any subdivision or combination of such Common Stock, or
in the case of any reorganization, reclassification, consolidation, merger, or
sale of the character referred to in Section 4(e) hereof, the stock or other
securities or property provided for in such Section.

                  (iv) "TRADING DAY" shall mean any day on which the Common
Stock is traded for any period on the OTCBB, or on the principal securities
exchange or other securities market on which the Common Stock is then being
traded.

      5. ISSUE TAX. The issuance of certificates for Warrant Shares upon the
exercise of this Warrant shall be made without charge to the holder of this
Warrant or such shares for any issuance tax or other costs in respect thereof,
provided that the Company shall not be required to pay any tax which may be
payable in respect of any transfer involved in the issuance and delivery of any
certificate in a name other than the holder of this Warrant.

      6. NO RIGHTS OR LIABILITIES AS A STOCKHOLDER. This Warrant shall not
entitle the holder hereof to any voting rights or other rights as a stockholder
of the Company. No provision of this Warrant, in the absence of affirmative
action by the holder hereof to purchase Warrant Shares, and no mere enumeration
herein of the rights or privileges of the holder hereof, shall give rise to any
liability of such holder for the Exercise Price or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

      7. TRANSFER, EXCHANGE, AND REPLACEMENT OF WARRANT.

            (a) RESTRICTION ON TRANSFER. This Warrant and the rights granted to
the holder hereof are transferable, in whole or in part, upon surrender of this
Warrant, together with a properly executed assignment in the form attached
hereto, at the office or agency of the Company referred to in Section 7(e)
below, provided, however, that any transfer or assignment shall be subject to
the conditions set forth in Section 7(f) hereof and to the applicable provisions
of the Securities Purchase Agreement. Until due presentment for registration of
transfer on the books of the Company, the Company may treat the registered
holder hereof as the owner and holder hereof for all purposes, and the Company
shall not be affected by any notice to the contrary. Notwithstanding anything to
the contrary contained herein, the registration rights described in Section 8
are assignable only in accordance with the provisions of the Registration Rights
Agreement.

            (b) WARRANT EXCHANGEABLE FOR DIFFERENT DENOMINATIONS. This Warrant
is exchangeable, upon the surrender hereof by the holder hereof at the office or
agency of the Company referred to in Section 7(e) below, for new Warrants of
like tenor representing in the aggregate the right to purchase the number of
shares of Common Stock, in not less than 25,000 increments, which may be

                                       8
<PAGE>

purchased hereunder, each of such new Warrants to represent the right to
purchase such number of shares as shall be designated by the holder hereof at
the time of such surrender.

            (c) REPLACEMENT OF WARRANT. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction, or mutilation of
this Warrant and, in the case of any such loss, theft, or destruction, upon
delivery of an indemnity agreement reasonably satisfactory in form and amount to
the Company, or, in the case of any such mutilation, upon surrender and
cancellation of this Warrant, the Company, at its expense, will execute and
deliver, in lieu thereof, a new Warrant of like tenor.

            (d) CANCELLATION; PAYMENT OF EXPENSES. Upon the surrender of this
Warrant in connection with any transfer, exchange, or replacement as provided in
this Section 7, this Warrant shall be promptly canceled by the Company. The
Company shall pay all taxes (other than securities transfer taxes) and all other
expenses (other than legal expenses, if any, incurred by the holder or
transferees) and charges payable in connection with the preparation, execution,
and delivery of Warrants pursuant to this Section 7.

            (e) REGISTER. The Company shall maintain, at its principal executive
offices (or such other office or agency of the Company as it may designate by
notice to the holder hereof), a register for this Warrant, in which the Company
shall record the name and address of the person in whose name this Warrant has
been issued, as well as the name and address of each transferee and each prior
owner of this Warrant.

            (f) EXERCISE OR TRANSFER WITHOUT REGISTRATION. If, at the time of
the surrender of this Warrant in connection with any exercise, transfer, or
exchange of this Warrant, this Warrant (or, in the case of any exercise, the
Warrant Shares issuable hereunder), shall not be registered under the Securities
Act and under applicable state securities or blue sky laws, the Company may
require, as a condition of allowing such exercise, transfer, or exchange, (i)
that the holder or transferee of this Warrant, as the case may be, furnish to
the Company a written opinion of counsel, which opinion and counsel are
acceptable to the Company, to the effect that such exercise, transfer, or
exchange may be made without registration under said Act and under applicable
state securities or blue sky laws, (ii) that the holder or transferee execute
and deliver to the Company an investment letter in form and substance acceptable
to the Company and (iii) that the transferee be an "accredited investor" as
defined in Rule 501(a) promulgated under the Securities Act; provided that no
such opinion, letter or status as an "accredited investor" shall be required in
connection with a transfer pursuant to Rule 144 under the Securities Act. The
first holder of this Warrant, by taking and holding the same, represents to the
Company that such holder is acquiring this Warrant for investment and not with a
view to the distribution thereof.

      8. REGISTRATION RIGHTS.

            (a) PIGGYBACK REGISTRATION. If the Company at any time during the
Registration Period (defined below), proposes to register any of its Common
Stock under the Securities Act of 1933, as amended (the "Act") on Forms S-1,
S-2, S-3 or SB-1, or SB-2 (but not Form S-4 or Form S-8 or other comparable
form) or on any other form upon which may be registered Common Stock, it will at
each such time give prompt written notice prior to the filing of the
registration statement to Holder of its intention so to do. Such notice shall
specify the proposed date of the filing of the registration statement and advise
Holder of its right to participate therein. Upon the written request of Holder
given prior to the proposed date of filing set forth in such notice, the Company
will cause each Warrant Share which the Company has been requested to register
by Holder to be registered under the Act, all to the extent requisite to permit
the sale or other disposition by Holder of the Warrant Shares so registered. The
term "Registration Period" shall mean the period commencing on the date hereof
and ending on the date on which the

                                       9
<PAGE>

Warrant Shares may be immediately sold to the public without registration or
restriction (including, without limitation, as to volume by the holder thereof),
under the Act.

      If, in the written opinion of the underwriter or underwriters managing the
public offering which is the subject of a registration pursuant to this Section
8(a) (or in the event that such distribution shall not be underwritten, in the
written opinion of an investment banking firm of recognized standing), the total
amount of shares of Common Stock to be so registered, when added to the total
amount of Warrant Shares which the Holder and all other Warrantholders have
requested to be registered pursuant to this Section 8(a), will exceed the
maximum amount of Common Stock of the Company which can be marketed: (i) at a
price reasonably related to their then current market value; or (ii) without
otherwise materially and adversely affecting the entire offering, then the
Company shall have the right to exclude from such registration such number of
Warrant Shares of Holder and the other Warrantholders which it would otherwise
be required to register pursuant to this Section 8(a) as is necessary to reduce
the total amount of shares of Common Stock of the Company to be so registered to
the maximum amount of shares of Common Stock which can be so marketed; provided,
however, that if the total amount of shares of Common Stock which can be sold is
less than the number of Warrant Shares requested by Holder and the other
Warrantholders to be included in the registration together with the number of
other shares of Common Stock duly requested to be registered by any affiliates
of the Company and other selling security holders included in the registration
statement who are subject to contractual cut-back agreements, then the number of
shares of Common Stock to be excluded from such registration shall be allocated
among Holder, and such other Warrantholders, affiliates and selling security
holders in proportion to the respective number of shares of Common Stock held of
record by each of them. In such event, the Company shall give Holder prompt
written notice of the number of shares of Holder's Warrant Shares excluded from
such registration at the request of the managing underwriter. No such exclusion
shall reduce the securities being offered by the Company for its own account to
be included in such registration statement.

      The Company may, in its sole discretion and without the consent of Holder,
at any time after it shall have given written notice to Holder in accordance
with this Warrant, delay the filing or effectiveness of the registration
statement or withdraw such registration statement and abandon the proposed
offering in which Holder had requested to participate; provided, however, that
such delay, withdrawal and/or abandonment is with respect to all securities
under such registration, and provided further, that any delay, withdrawal and/or
abandonment shall not preclude or otherwise prejudice subsequent requests for
registration pursuant to this Section 8.

      Holder will cooperate with the Company in all material respects in
connection with this Agreement, including, without limitation, timely supplying
all information reasonably requested by the Company and executing and returning
all documents reasonably requested in connection with the registration and sale
of the Warrant Shares.

      In connection with each registration covering an underwritten public
offering, the Company and Holder agree to enter into a written agreement with
the managing underwriter containing such provisions as are customary in the
securities business for such an arrangement between an underwriter and companies
of the Company's size and investment stature.

            (b) COMPANY'S OBLIGATIONS IN REGISTRATION. If and whenever the
Company is obligated by the provisions of this Section 8 to effect the
registration of any Warrant Shares under the Act, as expeditiously as possible
the Company will:

                  (i) prepare and file with the Commission a registration
statement and use its best efforts to cause such registration statement to
become and remain effective during the period required

                                       10
<PAGE>

for the distribution of the securities covered by the registration statement;
provided, however, that in the event that the Warrant Shares covered by such
registration statement are not to be sold to or through underwriters acting for
the Company, the Company shall not be required to keep such registration
statement in effect, or to prepare and file any amendments or supplements
thereto, for any period longer than that required under that certain
Registration Rights Agreement dated December 6, 2004 by and among the Company
and the investors who are signatories thereto;

                  (ii) prepare and file with the Commission such amendments and
supplements to such registration statement and the prospectus used in connection
therewith as may be necessary to keep such registration statement effective and
to comply with the provisions of the Act with respect to the disposition of all
Warrant Shares covered by such registration statement, whenever the Holder for
whom such Warrant Shares are registered shall desire to dispose of the same,
subject, however to the proviso contained in Section 8(b) above;

                  (iii) furnish to the Holder for whom such Warrant Shares are
registered and to any underwriter or underwriters such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as Holder may reasonably
request in order to facilitate the disposition of such Warrant Shares;

                  (iv) subject to Section 8(c) herein, use its reasonable
efforts to register or qualify the Warrant Shares covered by such registration
statement under such other securities or blue sky laws of such jurisdictions as
the Holder for whom such Warrant Shares are registered or are to be registered
shall reasonably request, except that the Company shall not for any such purpose
be required to: (i) qualify to do business as a foreign corporation in any
jurisdiction wherein it is not so qualified or to file therein any general
consent to service of process or be subject to any escrow or other similar
conditions; or (ii) take any other actions or submit itself or its directors or
officers to any restrictions, obligations or burdens having a material adverse
economic effect on it or them.

            (c) PAYMENT OF REGISTRATION EXPENSES. The costs and expenses of all
registrations under the Act and of all other actions which the Company is
required to take or effect pursuant to this Section 8 shall be paid for by the
Company (including, without limitation, all registration, qualification and
filing fees, printing expenses, expenses of distributing prospectuses and other
documents, fees and disbursements of counsel and accountants for the Company,
and expenses of any special audits incident to or required in connection with
any such registration hereof, but excluding the fees and disbursements of
special counsel for Holder or the other Warrantholders, any consultants retained
by Holder and underwriters' or brokers' discounts or commissions applicable to
any Warrant Shares).

            (d) INFORMATION FROM HOLDER. Notices and requests delivered by
Holder to the Company pursuant to this Section 8 shall contain such information
regarding Holder and Holder's Warrant Shares and the intended method of
disposition thereof as shall reasonably be required in connection with the
action to be taken.

            (e) COMPANY'S INDEMNIFICATION. To the extent permitted by law, the
Company shall indemnify and hold harmless Holder and each of its officers,
partners, directors, employees and representatives, each underwriter of such
Warrant Shares thereunder and each other person, if any, who controls Holder or
such underwriter within the meaning of the Act, against any losses, damages,
costs, claims, expenses and liabilities, including, without limitation,
reasonable attorneys', paralegals' and accountants' fees and expenses, before
and at trial and at all applicable appellate levels (individually and
collectively, "Losses"), to which they may become subject under the Act or other
federal or state law, insofar as such Losses arise out of or are based upon (i)
any untrue statement or alleged untrue statement of a material fact contained in
such registration statement including any preliminary prospectus or final

                                       11
<PAGE>

prospectus contained therein or any amendments or supplements thereto, and/or
(ii) the omission or alleged omission to state therein a material fact required
to be stated therein, or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading; provided, however,
that the Company shall not be liable in any such case if and to the extent that
any such Losses arise out of or are based upon (i) an untrue statement or
alleged untrue statement or omission or alleged omission so made in conformity
with information furnished by Holder, any such underwriter or any such
controlling person in writing specifically for use in such registration
statement or prospectus; or (ii) Holder's failure to deliver a copy of the final
prospectus as then amended or supplemented after the Company has furnished
Holder with a sufficient number of copies of the same, but only if delivery of
same is required by law and the same would have cured the defect giving rise to
any such Losses.

           (f) HOLDER'S INDEMNIFICATION. In the event of a registration of any
of Holder's Warrant Shares under the Act pursuant to the provisions of this
Agreement, Holder shall furnish to the Company in writing such information and
affidavits with respect to Holder as the Company reasonably requests for use in
connection with any such registration statement (or prospectus contained
therein) and Holder will indemnify and hold harmless to the extent permitted by
law, the Company, each person, if any, who controls the Company within the
meaning of the Act, each officer and director of the Company, each underwriter
and each person who controls any underwriter within the meaning of the Act,
against all Losses to which the Company or such officer, director, underwriter
or controlling person may become subject under the Act or otherwise, insofar as
such Losses arise out of or are based upon any statements or information
provided in writing by Holder, including each of its officers, partners,
directors, employees and representatives, to the Company or underwriter in
connection with the offer and sale of Warrant Shares. Notwithstanding the
foregoing, the amount Holder shall be obligated to indemnify pursuant to this
Agreement shall be limited to an amount equal to the proceeds received by Holder
of the Warrant Shares sold pursuant to the registration statement which gives
rise to such obligation to indemnity (less the aggregate amount which Holder has
been otherwise required to pay in respect of such Loss or any substantially
similar Loss arising from the sale of such Warrant Shares).

            (g) CONDUCT OF INDEMNIFICATION PROCEEDINGS. Any person entitled to
indemnification hereunder will: (a) give prompt written notice to the
indemnifying party of any claim with respect to which it seeks indemnification;
and (b) unless, in such indemnified party's reasonable judgment, a conflict of
interest may exist between such indemnified and indemnifying parties with
respect to such claim, permit such indemnifying party to assume the defense of
such claim with counsel reasonably satisfactory to the indemnified party;
provided, however, that the failure of an indemnified party to give notice as
provided herein shall not relieve the indemnifying party of its obligations
under this Section 8(g) with respect to such indemnified party, except to the
extent that the indemnifying party is actually prejudiced by such failure.
Whether or not such defense is assumed by the indemnifying party, the
indemnifying party will not be subject to any liability for any settlement made
without its consent (but such consent will not be unreasonably withheld). No
indemnifying party will consent to the entry of any judgment or enter into any
settlement which does not include as an unconditional term thereof the giving by
the claimant or plaintiff to such indemnified party of a release from all
liability in respect of such claim or litigation. An indemnifying party who is
not entitled to, or elects not to, assume the defense of the claim against the
indemnified party, will not be obligated to pay the fees and expenses of more
than one counsel for all parties indemnified by such indemnifying party with
respect to such claim, unless in the reasonable judgment of any indemnified
party a conflict of interest may exist between such indemnified party and any
other such indemnified parties with respect to such claim, in which event the
indemnifying party shall be obligated to pay the fees and expenses of such
additional counsel or counsels.

      If for any reason the indemnification provided for in the preceding
Sections 8(e) and 8(f) above is unavailable to an indemnified party as
contemplated thereby, the indemnifying party shall contribute to the amount paid
or payable by the indemnified party as a result of such loss, claim, damage or
liability in

                                       12
<PAGE>

such proportion as is appropriate to reflect not only the relative benefits
received by the indemnified party and the indemnifying party, but also the
relative fault of the indemnified party and the indemnifying party, as well as
any other relevant equitable considerations. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of fraudulent
misrepresentation.

      9. NOTICES. All notices, requests, and other communications required or
permitted to be given or delivered hereunder to the holder of this Warrant shall
be in writing, and shall be personally delivered, or shall be sent by certified
or registered mail or by recognized overnight mail courier, postage prepaid and
addressed, to such holder at the address shown for such holder on the books of
the Company, or at such other address as shall have been furnished to the
Company by notice from such holder. All notices, requests, and other
communications required or permitted to be given or delivered hereunder to the
Company shall be in writing, and shall be personally delivered, or shall be sent
by certified or registered mail or by recognized overnight mail courier, postage
prepaid and addressed, to the office of the Company at 516 Paul Morris Drive,
Englewood, Florida 34223, Attention: Chief Financial Officer, or at such other
address as shall have been furnished to the holder of this Warrant by notice
from the Company. Any such notice, request, or other communication may be sent
by facsimile, but shall in such case be subsequently confirmed by a writing
personally delivered or sent by certified or registered mail or by recognized
overnight mail courier as provided above. All notices, requests, and other
communications shall be deemed to have been given either at the time of the
receipt thereof by the person entitled to receive such notice at the address of
such person for purposes of this Section 9, or, if mailed by registered or
certified mail or with a recognized overnight mail courier upon deposit with the
United States Post Office or such overnight mail courier, if postage is prepaid
and the mailing is properly addressed, as the case may be.

      10. GOVERNING LAW. THIS WARRANT SHALL BE ENFORCED, GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO
AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD
TO THE PRINCIPLES OF CONFLICT OF LAWS. THE PARTIES HERETO HEREBY SUBMIT TO THE
EXCLUSIVE JURISDICTION OF THE UNITED STATES FEDERAL COURTS LOCATED IN NEW YORK,
NEW YORK WITH RESPECT TO ANY DISPUTE ARISING UNDER THIS WARRANT, THE AGREEMENTS
ENTERED INTO IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR
THEREBY. BOTH PARTIES IRREVOCABLY WAIVE THE DEFENSE OF AN INCONVENIENT FORUM TO
THE MAINTENANCE OF SUCH SUIT OR PROCEEDING. BOTH PARTIES FURTHER AGREE THAT
SERVICE OF PROCESS UPON A PARTY MAILED BY FIRST CLASS MAIL SHALL BE DEEMED IN
EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON THE PARTY IN ANY SUCH SUIT OR
PROCEEDING. NOTHING HEREIN SHALL AFFECT EITHER PARTY'S RIGHT TO SERVE PROCESS IN
ANY OTHER MANNER PERMITTED BY LAW. BOTH PARTIES AGREE THAT A FINAL
NON-APPEALABLE JUDGMENT IN ANY SUCH SUIT OR PROCEEDING SHALL BE CONCLUSIVE AND
MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER
LAWFUL MANNER. THE PARTY WHICH DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER
THIS WARRANT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING
ATTORNEYS' FEES, INCURRED BY THE PREVAILING PARTY IN CONNECTION WITH SUCH
DISPUTE.

      11. [INTENTIONALLY OMITTED]

      12. MISCELLANEOUS.

            (a) AMENDMENTS. This Warrant and any provision hereof may only be
amended by an instrument in writing signed by the Company and the holder hereof.

            (b) DESCRIPTIVE HEADINGS. The descriptive headings of the several
paragraphs of this Warrant are inserted for purposes of reference only, and
shall not affect the meaning or construction of any of the provisions hereof.

                                       13
<PAGE>

            (c) REMEDIES. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to the holder, by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the
Company acknowledges that the remedy at law for a breach of its obligations
under this Warrant will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Warrant, that the
holder shall be entitled, in addition to all other available remedies at law or
in equity, and in addition to the penalties assessable herein, to an injunction
or injunctions restraining, preventing or curing any breach of this Warrant and
to enforce specifically the terms and provisions thereof, without the necessity
of showing economic loss and without any bond or other security being required.

                  [remainder of page intentionally left blank]

                                       14
<PAGE>

            IN WITNESS WHEREOF, the Company has caused this Warrant to be signed
by its duly authorized officer.

                                      SINOFRESH HEALTHCARE, INC.

                                      By:       /s/ Charles A. Fust
                                          -------------------------------------
                                               Charles A. Fust
                                               Chief Executive Officer

Dated January 5, 2005.

<PAGE>

                           FORM OF EXERCISE AGREEMENT

                              ELECTION TO PURCHASE

                (To be signed only upon exercise of the Warrant)

TO:      SinoFresh HealthCare. Inc.

The undersigned, hereby irrevocably elects to exercise the purchase rights
represented by the Warrant granted to the undersigned on ______________ and to
purchase thereunder ____________ shares of Common Stock of SinoFresh HealthCare,
Inc. (the "Company") and herewith encloses either payment of $_______________ or
instructions regarding the manner of exercise permitted under Section 1(c) of
the Warrant, in full payment of the purchase price of such shares being
purchased.

Dated:

                             ___________________________________________________
                             (Signature must conform in all respects to name of
                             holder as specified on the face of the Warrant)

                             ___________________________________________________
                             (Please Print Name)

                             ___________________________________________________
                             (Address)

and, if said number of shares of Common Stock shall not be all the shares
purchasable under the within Warrant, a new Warrant is to be issued in the name
of said undersigned covering the balance of the shares purchasable thereunder
less any fraction of a share paid in cash.

<PAGE>

                               FORM OF ASSIGNMENT

      FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers
all the rights of the undersigned under the within Warrant, with respect to the
number of shares of Common Stock covered thereby set forth hereinbelow, to:

      Name of Assignee                 Address                     No. of Shares

, and hereby irrevocably constitutes and appoints _____________________________
as agent and attorney-in-fact to transfer said Warrant on the books of the
within-named corporation, with full power of substitution in the premises.

Dated:   ________ __, 200_

In the presence of:                     ________________________________________

                             Name:      ________________________________________

                             Signature: ________________________________________
                             Title of Signing Officer or Agent (if any):

                                        ________________________________________
                             Address:   ________________________________________
                                        ________________________________________

                             Note: The above signature should correspond exactly
                                   with the name on the face of the within
                                   Warrant, if applicable.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]